Home About Us Services Markets Resarch Online Trading Back Office Contact Us Download
Glaxosmithkline Pharmaceuticals Ltd Pharmaceuticals - Multinational
 BSE Code
 500660
ISIN Demat
INE159A01016
Book Value
91.3566062
Mar.Cap(Rs.Cr)
35,635.41
P/E
56.06
Face Value
10
Go
Your are on :   Markets   |  Company Profile   |  Key Financial Ratios
   YearsMar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Debt-Equity Ratio0.010.010.010.000.00
Long Term Debt-Equity Ratio0.000.010.010.000.00
Current Ratio1.831.891.771.591.41
Fixed Assets5.235.382.843.206.45
Inventory6.776.215.806.656.34
Debtors16.1815.2918.5229.2823.40
Interest Cover Ratio462.57383.39178.31102.681207.75
PBIDTM (%)28.0825.8324.2422.7522.79
PBITM (%)26.0323.7121.5520.1921.23
PBDTM (%)28.0225.7724.1222.5622.77
CPM (%)20.9454.3118.978.6815.15
APATM (%)18.9052.1916.286.1113.60
ROCE (%)33.6032.1132.1028.3827.52
RONW (%)27.4380.4528.499.9020.15
Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226  |  LALKAR COMMODITIES PVT. LTD.: MCX: 10685 FMC: MCX/TCM/CORP/0655 | NSEL: 11300 | NCDEX: 1130 FMC No : NCDEX/TCM/CORP/1106
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)